Risedronate Sodium 30 Mg Film-Coated Tablets
Out of date information, search another
Package leaflet: Information for the patient
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
What is in this leaflet
J What Risedronate sodium is and what it is used for
What you need to know before you take Risedronate sodium How to take Risedronate sodium ^ Possible side effects
How to store Risedronate sodium Contents of the pack and other information
J What Risedronate sodium is and what it is used for
What Risedronate sodium is
Risedronate sodium belongs to a group of nonhormonal medicines called bisphosphonates which are used to treat bone diseases. It works directly on your bones to make them stronger and therefore less likely to break.
Bone is a living tissue. Old bone is constantly removed from your skeleton and replaced with new bone.
Paget's disease occurs when this process, called remodeling, happens too quickly and in a disordered way. The new bone that is produced is weaker than normal and the affected bones may become enlarged, painful and may fracture. Risedronate sodium changes the bone remodeling process back to normal, returning the strength to the bone structure.
What Risedronate sodium is used for
Risedronate sodium is used for treatment for Paget's disease.
What you need to know before you take Risedronate sodium
Do not take Risedronate sodium:
• if you are allergic to risedronate sodium or any of the other ingredients of this medicine (listed in section 6)
• if your doctor has told you that you have a condition called hypocalcaemia (a low blood calcium level)
• if you may be pregnant, are pregnant or planning to become pregnant
• if you are breast-feeding
• if you have severe kidney problems.
Warnings and precautions
Talk to your doctor or pharmacist before taking
Risedronate sodium
• if you are unable to stay in an upright position (sitting or standing) for at least 30 minutes.
• if you have abnormal bone and mineral metabolism (for example lack of vitamin D, parathyroid hormone abnormalities, both leading to a low blood calcium level).
• if you have had problems in the past with your oesophagus (the tube that connects your mouth with your stomach). For instance you may have had pain or difficulty in swallowing food or you have previously been told that you have Barratt's oesophagus (a condition associated with changes in the cells that line the lower oesophagus).
• if you have been told by your doctor that you have an intolerance to some sugars (such as lactose).
• if you have had or have pain, swelling or numbness of the jaw or a “heavy jaw feeling” or loosening of a tooth.
• if you are under dental treatment or will undergo dental surgery, tell your dentist that you are being treated with Risedronate sodium.
Your doctor will advise you on what to do when taking Risedronate sodium if any of the above applies to you.
Children and adolescents
Risedronate sodium is not recommended for use in children below age 18 due to insufficient data on safety and efficacy.
Other medicines and Risedonate sodium
Medicinal products containing one of the following lessen the effect of Risedronate sodium if taken at the same time:
• calcium
• magnesium
• aluminium (for example some indigestion mixtures)
• iron.
Take these medicines at least 30 minutes after your Risedronate sodium tablet.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Risedronate sodium with food and drink
It is very important that you do NOT take your Risedronate sodium tablet with food or drinks (other than plain water) so that it can work properly. In particular do not take this medicine at the same time as dairy products (such as milk) as they contain calcium (see section 2, “Other medicines and Risedronate sodium”). Take food and drinks (other than plain water) at least 30 minutes after your Risedronate sodium tablet.
Pregnancy and breast-feeding
Do not take Risedronate sodium if you may be pregnant, are pregnant or planning to become pregnant (see section 2, “Do not take Risedronate sodium”). The potential risk associated with the use of Risedronate sodium in pregnant women is unknown. Do not take Risedronate sodium if you are breastfeeding (see section 2, “Do not take Risedronate sodium”).
Driving and using machines
Risedronate sodium is not known to affect your ability to drive and use machines.
Risedronate sodium 30 mg film-coated tablets contain lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
How to take Risedronate sodium
Dosage
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Recommended dose:
Take one Risedronate sodium tablet (30 mg of risedronate sodium) once a day.
The usual length of treatment is 2 months.
When to take the Risedronate sodium tablet
Take your tablet at least 30 minutes before the first food, drink (other than plain water) or other medicine of the day.
If you are unable to take your Risedronate sodium tablet at this time, you may take it on an empty stomach, at the same time every day, in one of the following ways:
• Either
Between meals: Risedronate sodium should be taken at least 2 hours before and at least 2 hours after any food, medicinal product or drink (other than plain water).
• Or
In the evening: Risedronate sodium should be taken at least 2 hours after the last food, medicinal product or drink (other than plain water) of the day. Risedronate sodium should be taken at least 30 minutes before going to bed.
How to take the Risedronate sodium tablet
• Take the tablet whilst you are in an upright position (you may sit or stand) to avoid heartburn.
• Swallow it with at least one glass (120 ml) of plain water.
• Swallow it whole. Do not suck or chew it.
• Do not lie down for 30 minutes after taking your tablet.
Your doctor will tell you if you need calcium and vitamin supplements, if you are not getting enough from your diet.
AAAF2146
|
colours/plates: | |||
|
1. black | |||
|
item no: AAAF2146 |
dimensions: 170 x 380 |
2. | |
|
print proof no: 3 |
pharmacode: |
3. | |
|
4. | |||
|
origination date: 11.4.13 |
min pt size: 8.5, 9.5, 10.5 pt |
5. | |
|
originated by: |
6. | ||
|
approved for print/date |
revision date: 29.5.13 |
Technical Approval |
Non Printing Colours |
|
1. | |||
|
revised by: |
date sent: 11.4.13 | ||
|
2. | |||
|
supplier: Iceland |
approved: |
3. | |
If you take more Risedronate sodium than you should
If you or somebody else has accidentally taken more Risedronate sodium tablets than prescribed, drink one full glass of milk and seek medical attention.
If you forget to take Risedronate sodium
If you forget to take Risedronate sodium tablet at the usual time, you can take the tablet according to the instructions above (i.e. before breakfast, between meals or in the evening).
Do not take a double dose to make up for a forgotten dose.
If you stop taking Risedronate sodium
Please talk to your doctor before you consider stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
^ Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Risedronate sodium and contact a doctor immediately if you experience any of the following:
• Symptoms of a severe allergic reaction, such as:
- Swelling of the face, tongue or throat
- Difficulties in swallowing
- Hives and difficulties in breathing
• Severe skin reactions that can include blistering of the skin.
Tell your doctor promptly if you experience the
following side effects:
• Eye inflammation, usually with pain, redness and light sensitivity.
• Bone necrosis of the jaw (osteonecrosis) associated with delayed healing and infection, often following tooth extraction (see section 2, “Warnings and precautions”).
• Symptoms from oesophagus such as pain when you swallow, difficulties in swallowing, chest pain or new or worsened heartburn.
However in clinical studies the other side effects that were observed were usually mild and did not cause the patient to stop taking their tablets.
The side effects are stated according to the frequency they occur. The following convention has been used: Very common: affects more than 1 user in 10 Common: affects 1 to 10 users in 100
Uncommon: affects 1 to 10 users in 1,000
Rare: affects 1 to 10 users in 10,000
Very rare. affects less than 1 user in 10,000
Not known: frequency cannot be estimated
from the available data
Common side effects
• Indigestion, feeling sick, stomach ache, stomach cramps or discomfort, constipation, feelings of fullness, bloating, diarrhoea.
• Pain in your bones, muscles or joints.
• Headache.
Uncommon side effects
• Inflammation or ulcer of the oesophagus (the tube that connects your mouth with your stomach) causing difficulty and pain in swallowing (see also section 2, “Warnings and precautions”), inflammation of the stomach and duodenum (bowel draining the stomach).
• Inflammation of the coloured part of the eye (iris) (red painful eyes with a possible change in vision).
Rare side effects
• Inflammation of the tongue (red swollen, possibly painful), narrowing of the oesophagus (the tube that connects your mouth with your stomach).
• Abnormal liver tests have been reported. These can only be diagnosed from a blood test.
During post-marketing experience, the following side effects have been reported (frequency unknown):
• Hair loss
• Liver disorders, some cases were severe
• Inflammation of small blood vessels mainly affecting the skin (leukocytoclastic vasculitis)
Rarely, at the beginning of treatment, a patient's blood calcium and phosphate levels may fall. These changes are usually small and cause no symptoms.
The following adverse events have been observed in a clinical study of Paget's disease patients: vision difficulties, breathing problems, cough, inflammation of large bowel, damage of the eye surface, cramps, dizziness, dry eye, flu symptoms, muscle weakness, abnormal growth of cells, a frequent need to pass water at night, unusual lumps or swellings, chest pain, rash, runny nose, ringing in the ears and weight loss.
Unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.
If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.
How to store Risedronate sodium
• Keep this medicine out of the sight and reach of children.
• Do not use this medicine after the expiry date which is stated on the label, carton and blister after EXP. The expiry date refers to the last day of that month.
• This medicinal product does not require any special storage conditions.
Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Contents of the pack and other information
What Risedronate sodium 30 mg film-coated tablets contain
• The active substance is risedronate sodium (amorphous). Each tablet contains 30 mg risedronate sodium, equivalent to 27.84 mg risedronic acid.
• The other ingredients are: magnesium stearate, crospovidone, lactose monohydrate, microcrystalline cellulose, hypromellose (E464), colloidal anhydrous silica, hydroxypropylcellulose (E463), macrogol 400, macrogol 8000, titanium dioxide (E171).
What Risedronate sodium 30 mg film-coated tablets look like and contents of the pack
Film-coated tablet.
White 8.5 mm round, biconvex, film-coated tablet.
Pack sizes:
Blisters: 7, 14, 28, 56, 84 film-coated tablets Tablet containers: 30 and 100 film-coated tablets
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Actavis Group PTC ehf.
Reykjavikurvegi 76-78 220 HafnarfjorSur Iceland
Manufacturer
Actavis hf.
Reykjavikurvegur 76-78 IS-220 HafnarfjorSur Iceland
This medicinal product is authorised in the Member States of the EEA under the following names:
Germany Risedronsaure-Actavis 30 mg
Filmtabletten
Italy Risedronato Actavis
Netherlands Risedronaat-natrium Actavis 30 mg United Kindgom Risedronate sodium 30mg film-coated tablets
This leaflet was last revised in May 2013.
^actavis
AAAF2146
Actavis, Barnstaple, EX32 8NS, UK
|
colours/plates: | |||
|
1. black | |||
|
item no: AAAF2146 |
dimensions: 170 x 380 |
2. | |
|
print proof no: 3 |
pharmacode: |
3. | |
|
4. | |||
|
origination date: 11.4.13 |
min pt size: 8.5, 9.5, 10.5 pt |
5. | |
|
originated by: |
6. | ||
|
approved for print/date |
revision date: 29.5.13 |
Technical Approval |
Non Printing Colours |
|
1. | |||
|
revised by: |
date sent: 11.4.13 | ||
|
2. | |||
|
supplier: Iceland |
approved: |
3. | |